A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.
about
Genome-wide epigenomic profiling for biomarker discoveryChromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks.Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrologyLongitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive diseaseThe 2016 revision of the World Health Organization classification of lymphoid neoplasms.Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2.DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaHigh-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsShort-Circuiting Gene Regulatory Networks: Origins of B Cell LymphomaPrognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.The molecular pathogenesis of chronic lymphocytic leukaemia.Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.Epigenetic modification of nucleic acids: from basic studies to medical applications.Chronic lymphocytic leukaemia genomics and the precision medicine era.The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity.Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemiaEpigenetic and Transcriptional Variability Shape Phenotypic Plasticity.Proteomics profiling of CLL versus healthy B-cells identifies putative therapeutic targets and a subtype-independent signature of spliceosome dysregulation.Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.Cancer epigenetics: Moving forward.Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets.Chronic lymphocytic leukaemiaNon-coding recurrent mutations in chronic lymphocytic leukaemiaEpigenetic variation taking center stage in immunological research
P2860
Q28080102-4AE2A9F2-C6CE-4F89-980B-6672717D466AQ33862792-CF2C5105-2B59-4F0D-98EA-800A33135A1FQ35026517-0974EC7A-D673-452E-AC79-E1B3656ECF28Q36884141-0261D958-5B35-46D5-81BA-4BEADEC87B86Q36920426-FAB8C9C7-418B-4E91-86AA-39EB631EFA6AQ37082635-CF4D8E01-EAFA-4D4C-AD8E-DD01D1293AE5Q37130889-6FBFD4C9-3CDA-4527-BB03-F5A8D8088CAAQ37209768-700BE7C6-4376-4A4C-A5B6-D92074BC5444Q38646971-29D1F5A4-98BA-4C5B-816F-245F4FA4FE2CQ38680890-EC6BB9BE-6466-4668-9469-2742DDE928ABQ38730980-7D59C8EC-C70D-41A4-9F9E-15C62D3828E9Q38748645-31305A07-11DA-46BB-9337-31DC480D9465Q39092611-ECE52ECA-A5A9-4513-B404-659B10BC4DD3Q39150343-4D11887A-CE9D-4C3C-AF32-CA21BAA50748Q39206156-04C26F74-C4CE-4DC6-80C5-21E93C07DA76Q39263974-6335E70D-F985-458F-B0EB-CE948C603662Q40929264-9A1F1EBD-F585-4D0E-B7E2-3E7B62F02251Q42371573-A6ADBF54-E1DA-4F1B-B3F8-70CBD97612BAQ49687100-5D59D473-F6D5-485A-9B8A-6A14D17771D7Q49788400-C1C11A9B-8B13-4375-9B63-78E584B7E56EQ50620646-2788E98B-4A46-47C9-A568-AC0EB09FD497Q55177661-125843DB-6882-4D85-B8A4-E06C274F7CC7Q55362703-B7C692E6-CFD7-4FC5-8790-75815DCD4795Q56270980-DC1CF047-564F-4F4F-A9FB-E0F73A16DD16Q56996904-AF12EF73-29BF-4283-BE4E-9AC87F939FDAQ57531292-87CC5FFE-2939-4328-9A07-1D25F2566F8F
P2860
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A B-cell epigenetic signature ...... leukemia with clinical impact.
@en
A B-cell epigenetic signature ...... leukemia with clinical impact.
@nl
type
label
A B-cell epigenetic signature ...... leukemia with clinical impact.
@en
A B-cell epigenetic signature ...... leukemia with clinical impact.
@nl
prefLabel
A B-cell epigenetic signature ...... leukemia with clinical impact.
@en
A B-cell epigenetic signature ...... leukemia with clinical impact.
@nl
P2093
P2860
P50
P356
P1433
P1476
A B-cell epigenetic signature ...... leukemia with clinical impact
@en
P2093
A C Queirós
A K Bergmann
A López-Guillermo
A Martinez-Trillos
E M M Penas
J Kolarova
P2860
P2888
P304
P356
10.1038/LEU.2014.252
P50
P577
2014-08-25T00:00:00Z